Published in Circ Res on July 01, 1970
Increased plasma adrenaline concentrations in benign essential hypertension. Br Med J (1977) 1.16
Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. J Clin Invest (1979) 0.90
Cardiovascular pathophysiology of essential hypertension: a clue to therapy. Drugs (1985) 0.86
Abnormalities of autonomic nervous control in human hypertension. Cardiovasc Drugs Ther (1994) 0.85
Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists. Br J Clin Pharmacol (1982) 0.79
Antihypertensive pharmacology. West J Med (1980) 0.77
Hypertension research program at ochsner: a program in translational research. Ochsner J (2002) 0.76
Essential hypertensive vascular disease: pathogenesis and pathophysiology. Bull N Y Acad Med (1981) 0.75
Dopamine-beta-hydroxylase. An index of adrenergic function in hypertensive patients. West J Med (1975) 0.75
Management of essential hypertension in the black patient: profiling as the initial approach to treatment. J Natl Med Assoc (1989) 0.75
Exercise test and 24-hour heart rate recording in men with high and low casual blood pressure levels. Br Heart J (1978) 0.75
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol (1972) 3.37
The heart in hypertension. N Engl J Med (1992) 2.53
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension (2001) 2.20
Renal insufficiency in treated essential hypertension. N Engl J Med (1989) 2.17
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension (1980) 1.95
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation (1968) 1.82
Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res (1981) 1.75
One-year longitudinal study of a no-smoking policy in a medical institution. Chest (1990) 1.75
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res (1974) 1.64
Evaluation of the initial care of hypertensive patients. JAMA (1971) 1.64
Report of the task force on blood pressure control in children. Pediatrics (1977) 1.60
Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med (1966) 1.57
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up. Cardiovasc Res (2000) 1.49
Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med (1979) 1.49
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
Three cases of hypotension and syncope with ventricular pacing: possible role of atrial reflexes. Am J Cardiol (1978) 1.44
Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther (1979) 1.42
Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol (1984) 1.41
Idiopathic hypovolemia. Ann Intern Med (1986) 1.40
The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol (1989) 1.39
Hypertension means high blood pressure. Hypertension (1994) 1.39
Remission of essential hypertension after renal transplantation. N Engl J Med (1983) 1.38
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
A pathologic-arteriographic correlation of renal arterial disease. Am Heart J (1966) 1.36
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients. Clin Sci Mol Med (1978) 1.30
Orthostatic hypotension: mechanisms and management. Am Heart J (1975) 1.29
Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res (1977) 1.27
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol (1984) 1.22
Obesity and hypertension. Ann Intern Med (1985) 1.19
Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med (1982) 1.19
Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med (1983) 1.18
Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med (1981) 1.18
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. Am J Cardiol (1974) 1.16
Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol (1979) 1.14
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Diuretic and diet treatment of hypertension. Arch Intern Med (1974) 1.13
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
The changing clinical spectrum of primary aldosteronism. Am J Med (1983) 1.11
Left ventricular hypertrophy and sudden death. J Am Coll Cardiol (1998) 1.11
Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med (1972) 1.11
Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am J Physiol (1978) 1.10
Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol (1980) 1.10
A renewed call to mentor. Hypertension (2000) 1.08
Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension (1980) 1.08
Editorial: Use and abuse of diuretics. Am Heart J (1975) 1.07
Vasodilating drugs: contrasting haemodynamic effects. Clin Sci Mol Med Suppl (1976) 1.06
Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control. Am J Cardiol (1982) 1.06
Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res (1976) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. Br Heart J (1984) 1.04
Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol (1984) 1.03
The multifactorial role of catecholamines in hypertensive cardiac hypertrophy. Eur Heart J (1982) 1.02
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (2001) 1.00
Recent advances on large arteries in hypertension. Hypertension (1998) 1.00